~~<i id='6FD8FF8B9A'><strike id='6FD8FF8B9A'><tt id='6FD8FF8B9A'><pre id='6FD8FF8B9A'></pre></tt></strike></i>~~

Home» leisure time» fashion

fashion

author：hotspot 2025-08-10 09:23:34 Page View：2698

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

explore

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

He's a Nobel laureate. Critics say he was misleading on Covid

Photoillustration:AlexHogan/STAT;Sourcephoto:AFPviaGettyOnedaylastAugust,astheystruggledtofigureoutw

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Meta looks to target Twitter with a rival app called Threads

Theannouncementofthesocialmediaapp'Threads'isdisplayedinApple'sUSAppStoreseenonthescreenofasmartphon